If you are talking about maximum residues, again, everybody does their own review and evaluation. The thing is that companies have to file those submissions. A Canadian farmer may not have access to those drugs because the drug submission has not been filed with Health Canada. That is why I say we all have a responsibility to encourage industry to bring those drugs to be filed with us.
I cannot tell you that by 2009 drugs will not be cheaper in the U.S., because we will need those generic companies to be filing drug submissions. It's all to do with industry's commitment to filing drug submissions, and that's what needs to be encouraged.